Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Titel:
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Auteur:
Wierda, William Kipps, Thomas Mayer, Jiří Stilgenbauer, Stephan Williams, Cathy D. Hellmann, Andrzej Robak, Tadeusz Furman, Richard R. Hillmen, Peter Trneny, Marek Dyer, Martin J.S. Padmanabhan, Swami Piotrowska, Magdalena Kozak, Tomas Chan, Geoffrey Davis, Randy Losic, Nedjad Wilms, Joris Russell, Charlotte Österborg, Anders